Pubblicazioni ufficiali Innate Pharma

Azioni

Tempo reale Euronext Paris Altri mercati azionari 11:43:45 15/05/2024			Variaz. 5gg	Var. 1 gen.
2,31 ^EUR	-0,65%		+0,87%	-11,83%

14/05	Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024
15/04	Innate Pharma annuncia l'avanzamento dell'attivatore delle cellule NK SAR443579 / IPH6101, sviluppato da Sanofi, alla Fase 2 per i pazienti affetti da cancro del sangue.	CI

Threshold crossings	21/10/22	CO
Provisional calendar	20/10/22	CO
Provisional calendar	20/10/22	CO
Slide show half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
1st-half-year results	15/09/22	CO
Half-year report	15/09/22	CO
Half-year report	15/09/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	31/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28/07/22	CO
Threshold crossings	18/07/22	CO
Corporate officers' Statement : Sale	29/06/22	CO
Corporate officers' Statement : Sale	17/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Corporate officers' Statement : Sale	14/06/22	CO
Slide show Q1	10/05/22	CO
1st quarter turnover	10/05/22	CO
1st quarter turnover	10/05/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	30/04/22	CO
Monthly statement on voting rights	28/02/22	CO
Monthly statement on voting rights	28/02/22	CO